(Q37767653)

22 August 2017

1 reference

title

New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance (English)

1 reference

22 August 2017

main subject

antibiotic resistance

1 reference

Jung Hun Lee

1

1 reference

22 August 2017

Il Kwon Bae

series ordinal

2

1 reference

22 August 2017

Sang Hee Lee

series ordinal

3

1 reference

22 August 2017

publication date

23 June 2010

1 reference

Medicinal Research Reviews

22 August 2017

published in

1 reference

22 August 2017

volume

32

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

216-232

1 reference

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

22 August 2017

cites work

1 reference

21 January 2018

Acinetobacter infection

1 reference

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

21 January 2018

1 reference

Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement

21 January 2018

1 reference

Redefining extended-spectrum beta-lactamases: balancing science and clinical need

21 January 2018

1 reference

A functional classification scheme for beta-lactamases and its correlation with molecular structure

21 January 2018

1 reference

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

21 January 2018

1 reference

Extended-spectrum beta-lactamases: a clinical update

21 January 2018

1 reference

Defining an extended-spectrum beta-lactamase

21 January 2018

1 reference

Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes

21 January 2018

1 reference

High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution

21 January 2018

1 reference

Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.

21 January 2018

1 reference

CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop

21 January 2018

1 reference

Natural D240G Toho-1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43.

21 January 2018

1 reference

Cefepime MIC as a predictor of the extended-spectrum beta-lactamase type in Klebsiella pneumoniae, Taiwan

21 January 2018

1 reference

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

21 January 2018

1 reference

Minor extended-spectrum beta-lactamases

21 January 2018

1 reference

Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development

21 January 2018

1 reference

Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-pectrum beta-lactamase in Pseudomonas aeruginosa in Thailand

21 January 2018

1 reference

Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium

21 January 2018

1 reference

Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital

21 January 2018

1 reference

A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli

21 January 2018

1 reference

OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa

21 January 2018

1 reference

OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa

21 January 2018

1 reference

OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene

21 January 2018

1 reference

Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate

21 January 2018

1 reference

Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate

21 January 2018

1 reference

Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 beta-lactamase confers increased MIC of cefepime

21 January 2018

1 reference

New disturbing trend in antimicrobial resistance of gram-negative pathogens

21 January 2018

1 reference

Genetic and biochemical characterization of GES-5, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae

21 January 2018

1 reference

Emergence in Klebsiella pneumoniae of a chromosome-encoded SHV beta-lactamase that compromises the efficacy of imipenem

21 January 2018

1 reference

Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.

21 January 2018

1 reference

Boronic acid disk tests for identification of extended-spectrum beta-lactamase production in clinical isolates of Enterobacteriaceae producing chromosomal AmpC beta-lactamases

21 January 2018

1 reference

Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli

21 January 2018

1 reference

Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis.

21 January 2018

1 reference

TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5).

21 January 2018

1 reference

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

21 January 2018

1 reference

Anti-infective research and development--problems, challenges, and solutions

21 January 2018

1 reference

Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase

21 January 2018

1 reference

Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion

21 January 2018

1 reference

The process of structure-based drug design

21 January 2018

1 reference

Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update

21 January 2018

1 reference

Hybrid QM/MM and DFT investigations of the catalytic mechanism and inhibition of the dinuclear zinc metallo-beta-lactamase CcrA from Bacteroides fragilis.

21 January 2018

1 reference

Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.

21 January 2018

1 reference

In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor

21 January 2018

1 reference

In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases

21 January 2018

1 reference

Structure-activity relationship of 6-methylidene penems bearing 6,5 bicyclic heterocycles as broad-spectrum beta-lactamase inhibitors: evidence for 1,4-thiazepine intermediates with C7 R stereochemistry by computational methods.

21 January 2018

1 reference

Inhibition of OXA-1 beta-lactamase by penems

21 January 2018

1 reference

The structure of β-lactamases

21 January 2018

1 reference

Comment on: Redefining extended-spectrum -lactamases: balancing science and clinical need

21 January 2018

1 reference

Redefining extended-spectrum -lactamases: balancing science and clinical need--authors' response

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MED.20210

1 reference

22 August 2017

1 reference